Last reviewed · How we verify
Bacillus Coagulans Tablets — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Bacillus Coagulans Tablets (Bacillus Coagulans Tablets) — Xijing Hospital of Digestive Diseases.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bacillus Coagulans Tablets TARGET | Bacillus Coagulans Tablets | Xijing Hospital of Digestive Diseases | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bacillus Coagulans Tablets CI watch — RSS
- Bacillus Coagulans Tablets CI watch — Atom
- Bacillus Coagulans Tablets CI watch — JSON
- Bacillus Coagulans Tablets alone — RSS
Cite this brief
Drug Landscape (2026). Bacillus Coagulans Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/bacillus-coagulans-tablets. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab